Skip to main content
SpringerLink
Log in

Cisatracurium besilate: a new nondepolarising neuromuscular relaxant

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bryson HM, Faulds D. Cisatracurium besilate: a review of its pharmacology and clinical potential in anaesthetic practice. Drugs 1997; 53(5): 849–866

    Article  Google Scholar 

  2. British National Formulary No. 31. London: The Pharmaceutical Press, 1996 Mar: 530–1

  3. Schmautz E, Deriaz H, Vrillon M, et al. Evaluation of 51W89 for endotracheal intubation in surgical patients during N20/02/propofol anesthesia [abstract no. A1081]. Anesthesiology 1994 Sep; 81 Suppl. 3A

    Article  Google Scholar 

  4. Bluestein LS, Stinson Jr LW, Lennon RL, et al. Evaluation of cisatracurium, a new neuromuscular blocking agent, for tracheal intubation. Can J Anaesth 1996 Sep; 43: 925–31

    Article  PubMed  CAS  Google Scholar 

  5. Littlejohn IH, Abhay K, El Sayed A, et al. Intubating conditions following 1R CIS, 1’R CIS atracurium (51W89): a comparison with atracurium. Anaesthesia 1995 Jun; 50: 499–502

    Article  PubMed  CAS  Google Scholar 

  6. Pavlin EG, Duvaldestin P, Belmont MR, et al. The use of cisatracurium for tracheal intubation. Curr Opin Anaesth 1996; 9 Suppl. 1: S23–6

    Google Scholar 

  7. Stout RG, Belmont MR, Pavlin EG, et al. Evaluation of intubation at 90 and 120 seconds following 51W89 administration [abstract no. A1078]. Anesthesiology 1994 Sep; 81 Suppl. 3A

    Article  Google Scholar 

  8. Prielipp RC, Coursin DB, Scuderi PE, et al. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995 Jul; 81: 3–12

    PubMed  CAS  Google Scholar 

  9. Chapple DJ, Miller AA, Ward JB, et al. Cardiovascular and neurological effects of laudanosine: studies in mice and rats, and in conscious and anaesthetized dogs. Br J Anaesth 1987; 59: 218–25

    Article  PubMed  CAS  Google Scholar 

  10. Lepage J-Y, Malinovsky J-M, Malinge M, et al. Pharmacodynamic dose-response and safety study of cisatracurium (51W89) in adult surgical patients during N2O-O2-opioid anesthesia. Anesth Analg 1996 Oct; 83: 823–9

    PubMed  CAS  Google Scholar 

  11. Oyos TL, Lillehaug SL, Harley PJ, et al. A study of the safety and efficacy of 51W89 in surgical patients during N2O/O2/opioid, N2O/O2/isoflurane, N2O/O2/enflurane, and N2O/O2/propofol anesthesia [abstract no. A1117]. Anesthesiology 1994 Sep; 81 Suppl. 3A

    Article  Google Scholar 

  12. Boyd AH, Eastwood NB, Parker CJR, et al. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Br J Anaesth 1996 Mar; 76: 382–8

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cisatracurium besilate: a new nondepolarising neuromuscular relaxant. Drugs Ther. Perspect 10, 1–5 (1997). https://doi.org/10.2165/00042310-199710020-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199710020-00001

Keywords

Search

Navigation